Not available
Quote | Viking Therapeutics Inc. (NASDAQ:VKTX)
Last: | $81.46 |
---|---|
Change Percent: | -2.26% |
Open: | $83.5 |
Close: | $83.34 |
High: | $84.7 |
Low: | $80.5 |
Volume: | 3,329,459 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Viking Therapeutics Inc. (NASDAQ:VKTX)
2024-03-28 05:50:00 ET What's the hottest biotech stock on the market right now? If we limit the list only to those with market caps of at least $500 million, it's Viking Therapeutics (NASDAQ: VKTX) . So far in 2024, Viking's shares have skyrocketed over 270% (and were up even highe...
2024-03-27 19:50:00 ET Summary Positive results achieved from phase 2 MOMENTUM study, whereby patients not only achieved significant weight loss over a 48-week period with pemvidutide but also had lean mass preservation. It is said that the GLP-1 market could exceed $100 billion b...
Message Board Posts | Viking Therapeutics Inc. (NASDAQ:VKTX)
Subject | By | Source | When |
---|---|---|---|
I picked up 6k shares today at 22. | randychub | investorshub | 05/16/2023 3:21:07 PM |
YES!!! Study Achieves Primary Endpoint, Demonstrating Statistically Significant | Glider549 | investorshub | 05/16/2023 11:12:12 AM |
Price now up | budgetthis | investorshub | 05/15/2023 11:34:23 AM |
$VKTX short squeeze article | roadkilll | investorshub | 05/14/2023 6:04:58 PM |
$VKTX we got news | roadkilll | investorshub | 05/14/2023 1:27:56 PM |
News, Short Squeeze, Breakout and More Instantly...
Viking Therapeutics Inc. Company Name:
VKTX Stock Symbol:
NASDAQ Market:
Viking Therapeutics Inc. Website:
2024-03-28 05:50:00 ET What's the hottest biotech stock on the market right now? If we limit the list only to those with market caps of at least $500 million, it's Viking Therapeutics (NASDAQ: VKTX) . So far in 2024, Viking's shares have skyrocketed over 270% (and were up even highe...
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter...
Tuesday, Viking Therapeutics Inc (NASDAQ:VKTX) released results from the company’s Phase 1 multiple ascending dose (MAD) trial of a...